<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02796976</url>
  </required_header>
  <id_info>
    <org_study_id>EKNZ-2015-351</org_study_id>
    <nct_id>NCT02796976</nct_id>
  </id_info>
  <brief_title>Exercise, Arterial Cross-Talk Modulation and Inflammation in an Ageing Population</brief_title>
  <acronym>ExAMIN AGE</acronym>
  <official_title>Exercise, Arterial Cross-Talk Modulation and Inflammation in an Ageing Population (ExAMIN AGE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Basel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Basel Institute of Clinical Epidemiology (BICE)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Basel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of the study are twofold. In the cross-sectional approach (Part I), the study will
      be conducted in an older population to assess the association of physical fitness on
      different parts of the human vascular bed. In the interventional approach (Part II), it aims
      to investigate whether and to what extent advanced vascular ageing (AVA) in older subjects
      with increased cardiovascular risk can be reversed by regular walking- based high intensity
      interval training.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the cross-sectional part the investigators analyze physical fitness, vascular health and
      further outcomes in a healthy older active, a healthy older sedentary and a obese sedentary
      group with increased cardiovascular risk. The investigators will analyze large and small
      artery function, physical fitness and activity as well as inflammatory parameters in these
      three groups. Here the investigators will investigate the influence of physical activity and
      inflammatory parameters on the vascular health in different beds.

      In the intervention part the older sedentary group with increasing cardiovascular risk (OSR)
      will be randomized in a control and an intervention group. The intervention group will get a
      high intensity interval training which is walking based and individual adjusted. The control
      group will get general lifestyle recommendations. After 12 weeks of training OSR group will
      be tasted again. The aim of the second part is to assess the effect of high intensity
      interval training on vascular health and inflammatory parameters.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of pulse wave velocity (m/s)</measure>
    <time_frame>Change from baseline pulse wave velocity at 12 weeks</time_frame>
    <description>Measured at local, central and peripheral site</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of augmentation index (AIx@75) in %</measure>
    <time_frame>Change from baseline augmentation index at 12 weeks</time_frame>
    <description>AIx and AIx@75 will be measured by using the gold standard device for single measurements (SphygmoCor®)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of arteriolar to venular diameter ratio (AVR) in µm</measure>
    <time_frame>Change from baseline AVR at 12 weeks</time_frame>
    <description>Dynamic and static retinal vessel analyzes will be investigated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of physical activity in METs per week</measure>
    <time_frame>Change from baseline physical activity at 12 weeks</time_frame>
    <description>The Freiburger Questionnaire of physical activity and inactivity and an accelerometer for seven days will be used to measure physical activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of physical fitness in VO2max</measure>
    <time_frame>Change from baseline VO2max at 12 weeks</time_frame>
    <description>An individual treadmill ramp test will be used to investigate peak oxygen consumption and maximal heart rate.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change of diastolic function parameters (E/A; E/E`)</measure>
    <time_frame>Change from baseline parameters at 12 weeks</time_frame>
    <description>Echocardiography</description>
  </other_outcome>
  <other_outcome>
    <measure>Change of autonomic function in heart rate variability (HRV) in beats per minute (bpm)</measure>
    <time_frame>Change from baseline HRV at 12 weeks</time_frame>
    <description>12-lead ECG monitoring</description>
  </other_outcome>
  <other_outcome>
    <measure>Change of serum biomarkers (hs-CRP, IL-6, IL-10, TNF-α)</measure>
    <time_frame>Change from baseline serum biomarkers at 12 weeks</time_frame>
    <description>Blood sampling</description>
  </other_outcome>
  <other_outcome>
    <measure>Change of cognitive Function</measure>
    <time_frame>Change from baseline cognitive function at 12 weeks</time_frame>
    <description>Executive function test battery</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Cardiovascular Disease</condition>
  <condition>Obesity</condition>
  <condition>Atherosclerosis</condition>
  <condition>Heart; Disease, Activity</condition>
  <arm_group>
    <arm_group_label>healthy older active</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>only cross-sectional</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy older sedentary</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>only cross-sectional</description>
  </arm_group>
  <arm_group>
    <arm_group_label>older sedentary at risk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cross-sectional and training or control condition</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Training or control condition</intervention_name>
    <description>Participants get a 12 week high intensity and walking-based interval training which is adapted to their individual physical fitness level or a general recommendation on physical activity according to European Guidelines.</description>
    <arm_group_label>older sedentary at risk</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men and women aged 50-79 years

          -  Active lifestyle: &gt; 9 MET/week (&gt; 3hours moderate walking/week); 18.5≤ BMI ≤ 29.9
             kg/m2

          -  Sedentary lifestyle: ≤ 3 MET/week (≤ 1 hour moderate walking/week); 18.5≤ BMI ≤ 29.9
             kg/m2

          -  Sedentary men and women aged 50-79 years with increased cardiovascular risk are
             allowed to have ≥ one additional cardiovascular risk factor

        Exclusion Criteria:

          -  History of cardiovascular, pulmonary or chronic inflammatory disease

          -  blood pressure ≥ 140/90 mmHg during 24h monitoring

          -  current or past smoker (in healthy group)

          -  macular degeneration or glaucoma

          -  compromising orthopaedic problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Henner Hanssen, Prof. Dr.</last_name>
    <phone>+ 41 (0)61 377 87 46</phone>
    <email>henner.hanssen@unibas.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lukas Streese, PhD cand.</last_name>
    <phone>+ 41 (0)61 377 87 51</phone>
    <email>lukas.streese@unibas.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bereich Sport- und Bewegungsmedizin, Abteilung Präventive Sportmedizin &amp; Systemphysiologie</name>
      <address>
        <city>Basel</city>
        <state>Basel Stadt</state>
        <zip>4052</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henner Hanssen, Prof. Dr.</last_name>
      <phone>+ 41 (0)61 377 87 46</phone>
      <email>henner.hanssen@unibas.ch</email>
    </contact>
    <contact_backup>
      <last_name>Lukas Streese, MSc.</last_name>
      <phone>+ 41 (0)61 377 87 51</phone>
      <email>lukas.streese@unibas.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Hanssen H, Nussbaumer M, Moor C, Cordes M, Schindler C, Schmidt-Trucksäss A. Acute effects of interval versus continuous endurance training on pulse wave reflection in healthy young men. Atherosclerosis. 2015 Feb;238(2):399-406. doi: 10.1016/j.atherosclerosis.2014.12.038. Epub 2014 Dec 23.</citation>
    <PMID>25558034</PMID>
  </reference>
  <reference>
    <citation>Nussbaumer M, Donath L, Fischer M, Schäfer J, Faude O, Zahner L, Schmidt-Trucksäss A, Hanssen H. Effects of acute bouts of endurance exercise on retinal vessel diameters are age and intensity dependent. Age (Dordr). 2014 Jun;36(3):9650. doi: 10.1007/s11357-014-9650-3. Epub 2014 Apr 12.</citation>
    <PMID>24728623</PMID>
  </reference>
  <reference>
    <citation>Hanssen H, Nickel T, Drexel V, Hertel G, Emslander I, Sisic Z, Lorang D, Schuster T, Kotliar KE, Pressler A, Schmidt-Trucksäss A, Weis M, Halle M. Exercise-induced alterations of retinal vessel diameters and cardiovascular risk reduction in obesity. Atherosclerosis. 2011 Jun;216(2):433-9. doi: 10.1016/j.atherosclerosis.2011.02.009. Epub 2011 Feb 17.</citation>
    <PMID>21392768</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2016</study_first_submitted>
  <study_first_submitted_qc>June 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2016</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Basel</investigator_affiliation>
    <investigator_full_name>Henner Hanssen</investigator_full_name>
    <investigator_title>Prof. Dr. med. Henner Hanssen</investigator_title>
  </responsible_party>
  <keyword>arterial stiffness</keyword>
  <keyword>retinal vessels</keyword>
  <keyword>physical activity</keyword>
  <keyword>ageing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

